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Abstract. Coriolus versicolor Queil is a mushroom traditionally used in Asian herbal
remedies. In the present study, C. versicolor alcoholic extract was tested on Ehrlich Ascitic Carcinoma
(EAC) model. The experiment was carried out on 30 white Swiss male mice, 106 EAC cells / animal
i.p. Animals were divided in three equal groups; first group (C. versicolor + EAC group) received in
the day 1, 4 and 7 - 50 ml sol./kg b.w. C. versicolor 1:10. The second group was the EAC group and
the last group (Doxorubicin + EAC group) received i.p. Doxorubicin cloride 2.5 mg/ kg b.w. in day 6
of experiment. Other 30 animals were subject of administration of mushroom extract, control and
Doxorubicine chloride alone in the same doses, at the same time. C. versicolor alcoholic extract
provides the significant increase in white blood cells, and the platelets as compared to control. The
survival rate was also higher in treated groups, and the extract was able to prevent in a significant
manner the increasing in the body weight do to accumulation of the ascitic fluid. C. versicolor
reduced, also, the ascitic volume and cellular concentration of the ascitic fluid, but not statistically
significant. C. versicolor alcoholic extract revealed a considerable antitumoral activity, along with the
safety profile; therefore C. versicolor is recommended for further studies, in other to find new
remedies in complementary cancer therapy.
Keywords: Corioulus versicolor, Ehrlich Ascitic Carcinoma, mice, Doxorubicine, body
weight.
INTRODUCTION
Coriolus versicolor Queil is a mushroom traditionally used in Asian herbal remedies.
The most important compounds are polysaccharide K (PSK) and polysaccharide-peptide
(PSP); they are being studied as possible complementary cancer treatments (Ergil et al.,
2002). Both polysaccharides have documented anticancer activity in vitro, in vivo and in
human clinical trials, though PSK has been researched longer and has therefore undergone
more thorough laboratory, animal and clinical testing. The mechanisms of biological response
modification by PSK have not fully elucidated (Ergil et al., 2002). Some studies suggest that
PSK may act to increase leukocyte activation through up-regulation of key cytokines (Shinjiro
et al., 2009). Indeed, natural killer and lymphocyte-activated killer cell activation has been
demonstrated in vivo and in vitro, (Ho et al., 2004). An antimetastatic action of PSK has also
been demonstrated throughout various mechanisms (Harhaji et al., 2008). PSK has also been
shown to cause differentiation of leukaemia cells in vitro, and this effect has been attributed to
induction of differentiation cytokines (Jiménez-Medina et al., 2008). Interestingly, studies
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have also shown that PSK may actually inhibit carcinogenesis by inhibiting the action of
various carcinogens on vulnerable cell lines. This action of PSK may play a role in preventing
second malignancies due to the carcinogenic effects of radiotherapy and cytotoxic
chemotherapy (Mitomi et al., 1992).
MATERIALS AND METHODS
Plant materials: The mushroom was harvested in Valenii de Munte surrounding area,
in September 2009.
Preparation of tincture: 10g of powdered vegetal product were extracted with 100g of
ethanol 70° at room temperature, as described in Romanian Pharmacopoeia Xth Edition.
To prevent toxic effect of the alcohol, often more toxic than plant compounds
dissolved in it, alcoholic solution was maintained in a water bath until 3/4 of the content
evaporates, than filed with sterile saline solution to 0.5 ml for each animal. The aqueous
solution was administrated i.p. within few minutes in order to prevent the bacterial and fungus
contamination.
The animals were caged in groups of 10 per cage, at controlled temperature of 21-
22ºC, humidity (40-60%) and reversed 12/12h light/dark cycle (light off at 10 a.m.). Standard
lab chow, provided by National Institute for Research and Development “Cantacuzino”
Bucharest (Batch no. 2 / 26.03.2010), and water were freely available. The animal tests and
experiments were allowed by the Bioethical Board of the Faculty of Veterinary Medicine
Cluj-Napoca.
The experiment was carried out on 30 white Swiss male mice, 36.69 ± 3.86 g body
weight; each animal received 106 Ehrlich Ascitic Carcinoma (EAC) cells intra peritoneal, in
the day 0 of the experiment. The experiment last for 14 days, in the Department of
Pathophysiology, University of Agricultural Science and Veterinary Medicine Cluj-Napoca.
Ehrlich ascitic carcinoma (EAC) was a generous gift from the Oncology Institute “I.
Chiricuta” Cluj Napoca. Body weight was measured at the beginning, and at the end of
experiment.
Animals were divided in three equal experimental groups; first group (C. versicolor +
EAC group) received i.p. in the day 1, 4 and 7 - 50 ml sol. /kg b.w. C. versicolor 1:10 plant to
extract in ethylic alcohol 70°. The second group, (EAC group) received 0.5 ml alcohol 70°, i.p
(after evaporation in water bath in the same way like the mushroom extract) and the last group
(Doxorubicin + EAC group) received i.p. Doxorubicin chloride 2.5 mg/ kg b.w.
(Adriablastina 10 mg – Phizer) in day 6 of experiment.
To assess the biological effects of substances in study, other 30 animals were subject
of administration of mushroom extract, control and Doxorubicine chloride alone in the same
doses, at the same time.
In the end, the blood was harvested from the retro orbitary sinus under diethyl ether
anesthesia and the euthanasia was made by prolonged ether narcosis. Total amount of ascitic
fluid was measured, and viable EAC cells concentration was counted in a Burker camera
(liquid diluted 1:200). Cell viability was assessed by tripan blue staining (Olinescu, 1992).
Blood hematology was investigated with Abacus Junior Vet, automatic analyzer
Diatron Messtechnik, Budapest, Hungary. Blood chemistry (urea and creatinin) was measured
using screen point semiautomatic analyzer, STAT – FAX 1904 Plus, Global Medical
Instrumentation, Inc. 6511 Bunker Lake Blvd. Ramsey Minnesota, 55303 USA, by using
special determination kits in the Department of Pathophysiology, University of Agricultural
Science and Veterinary Medicine Cluj-Napoca.
265
Statistics - the data were expressed as the mean and standard deviation. T Student
multiple range test from Excel Windows Software was used to assess the differences among
groups. Differences at p<0.05 and p<0.01 were considered significant and respectively
distinct significant.
RESULTS AND DISCUSSION
No significant changes in red blood cells has been found among experimental groups,
the total red blood cells count, hemoglobin, hematocrit and red cells indices were within
normal limit (Tab. 1, 2).
Tab. 1.
The hematological profile (mean ± S.D.)
RBC 1012/l HGB g/dl HCT %
EAC 6.48±1.21 9.46±1.95 28.73±5.63
EAC + Doxorubicin 7.04±0.90 11.75±1.60 35.99±4.67
EAC + C. versicolor 5.87±0.50 9.85±0.99 28.30±2.83
C. versicolor 7.38±0.67 11.76±0.76 35.36±2.94
Doxorubicin 7.33±0.98 11.26±1.29 34.35±5.26
Control 6.67±1.40 10.26±2.22 31.74±6.05
Normal values: RBC 7-12.5 1012/l HGB 10.2-18 g/dl HCT 36-49 % (Uray, 1992)
Tab. 2.
The Red Cell Indices (mean ± S.D.)
MCV fl MCH pg MCHC g/dl RDWs fl
EAC 44.20±3.35 14.56±0.83 33.00±1.61 42.06±5.26
EAC + Doxorubicin 51.00±1.82 16.72±0.48 32.70±0.36 37.30±1.92
EAC + C. versicolor 48.28±1.70 16.84±1.30 34.84±2.04 34.94±1.54
C. versicolor 48.00±3.39 16.00±1.22 33.32±0.87 35.66±5.63
Doxorubicin 46.80±3.08 15.31±1.32 32.66±1.13 39.06±3.60*
Control 47.78±2.11 15.34±0.59 32.13±1.025 34.03±4.03
Normal values: MCV 53.6-56 fl, MCH 48.1-50 pg, MCHC 31.3-33.2 g/dl (Uray, 1992)
Doxorubicin, as expected induce a significant leucopenia as compared to control group, and
interestingly was responsible for reducing the total white blood cell count (WBC) in EAC injected
groups (EAC inoculation was related to elevated WBC concentration).
Coriolus versicolor alcoholic extract provides significant increase in WBC as compared
to control mainly at granulocytes (GRA) suggesting a neutrophilia (Tab. 3). Some peritoneal local
reaction do to i.p. injection of plant extracts was excluded by gross evaluation and cytology of




The leukogram (mean ± S.D.)
WBC 109/l LYM 109/l MID 109/l GRA 109/l
EAC 62.32±45.82 9.15±6.61 2.58±3.58 50.56±44.44
EAC + Doxorubicin 15.01±9.46 8.93±3.014 0.34±0.39 5.64±6.37
EAC + C. versicolor 59.19±37.43 7.92±4.11 3.84±5.02 48.01±30.14
C. versicolor 7.50±2.27* 5.78±1.79 0.26±0.13* 1.47±0.47**
Doxorubicin 2.48±1.42** 1.74±0.94*** 0.11±0.10 0.64±0.49
Control 4.87±1.83 4.29±1.69 0.11±0.07 0.45±0.26
*= statistically significant at p<0.05 as compared to Control group
**= statistically distinct significant at p<0.01 as compared to Control group
***= highly statistically significant at p<0.001 as compared to Control group
Normal values WBC 6-15 109/l (Uray, 1992)
C. versicolor induces a significant increasing of the platelets (in concentration, and
average volume), but no significant changes among other groups (Tab. 4).
Tab. 4.
The platelets (mean ± S.D.)
PLT 109/l PCT % MPV fl PDWs fl
EAC 648.80±205.39 0.40±0.21 6.20±0.38 6.70±0.60
EAC + Doxorubicin 498.50±110.03 0.32±0.08 6.38±0.31 6.40±0.24
EAC + C. versicolor 897.00±360.37 0.63±0.26 7.00±0.42 7.69±0.80
C. versicolor 695.40±149.94** 0.42±0.11** 6.02±0.32 5.98±0.67
Doxorubicin 643.70±190.93 0.38±0.11* 5.91±0.17 5.88±0.42
Control 389.33±181.25 0.23±0.11 5.97±0.19 5.84±0.43
*= statistically significant at p<0.05 as compared to Control group
**= statistically distinct significant at p<0.01 as compared to Control group
***= highly statistically significant at p<0.001 as compared to Control group
Normal values PLT 160-410 109/l (Uray, 1992)
In EAC group only 8 from 10 animals survived in the end of the study, in the other
two experimental groups all animals survived to the end; development of EAC was
expectedly followed by a significant increasing in body weight. Doxorubicin revealed a
strong protective effect; in treated animals, the body weight was slightly decreased. Even no
so effective like Doxorubicin, Coriolus versicolor alcoholic extract provides a relevant









E A C E A C  +  D ox orub ic in E A C + C .vers ic o lo r
9 .52± 11 .29  %31 .73± 19 .76  %
-0 .78± 8 .25  %
*
**
Fig. 1. The variation on body weight among experimental groups (mean ± S.D.) (g)
*= statistically significant at p<0.05 as compared to Control group
**= statistically distinct significant at p<0.01 as compared to Control group
Both ascitic volume and cellular concentration of the ascitic fluid was highly
decreased in Doxorubicin treated groups, C. versicolor provides some protection, but not
statistically significant (Fig. 2, 3). However, this cytostatic effect should not be excluded, at
higher dosage. Important both substances provide cytostatic effects, and no citotoxic ones,
because tripan blue staining revealed almost 100% viable cells in ascitic fluid. Plasma
biochemistry, gross evaluation and histopathological exam reveal no significant lesion for
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*
Fig. 2. The ascitic volume (mean ± S.D.) (ml)










EAC EAC + Doxorubicin EAC + C.versicolor
*
Fig. 3. The cellular concentration within ascitic fluid (mean ± S.D.) (106/ml)
*= statistically distinct significant at p<0.05 as compared to Control group
Several clinical and experimental assays have reported the anti-tumor properties of C.
versicolor and its synergistic effect in combined therapies identified a new cytostatic anti-
tumor activity, and immunostimulatory effects of C. versicolor (Mitomi et al., 1992).
The combined administration of C. versicolor with IL-3 increased the haematological
recovery of myelosuppressed mice. The peripheral blood leukocyte count during the recovery
stage was significantly increased when these cytokines were administered with C. versicolor
compared to when the cytokines were used individually. Moreover, the phase at which C.
versicolor has effects on haematopoietic cells seems to be at a more immature level than with
IL-3. The combined administration of C. versicolor and the above cytokines may improve
myelosuppression after chemotherapy in patients with malignancy (Kohgo et al., 1994).
The cytostatic activity varied according to the histological origin of the tumor cell
lines in study, the inhibition was higher in melanoma cell lines Ando-2 (human) and B16
(mice) (Jiménez-Medina et al., 2008).
In vitro treatment of the cells with the methanol extract reduced melanoma cell
viability in a dose-dependent manner; the proliferation of B16 cells was arrested in the
G(0)/G(1) phase of the cell cycle, followed by both apoptotic and secondary necrotic cell
death. In vivo methanol extract treatment inhibited tumor growth in C57BL/6 mice inoculated
with syngeneic B16 tumor cells. Moreover, peritoneal macrophages collected 21 days after
tumour implantation from methanol extract-treated animals exerted stronger tumoristatic
activity than macrophages from control melanoma-bearing mice (Harhaji et al.,2008).
C. versicolor alcoholic extracts exert pronounced anti-tumor activity, both directly
through antiproliferative and cytostatic effects on tumor cells and indirectly through
promotion of macrophage, and generally cellular antitumor activity
CONCLUSIONS
C. versicolor alcoholic extract revealed certain antitumoral activity on Ehrlich Ascitic
Carcinoma model, proved not only by reduction of tumor cells proliferation, but
hematological data suggest significant immunostimulatory effects. No side effect toxicity has
been found. C. versicolor alcoholic extract are not yet ascertained, its powerful antitumoral
activity, along with the safety profile, recommend alcoholic extract of C. versicolor for
further studies, in other to find new remedies in complementary cancer therapy.
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